Final report of the Lyme disease review panel of the Infectious Diseases Society of America: A pyrrhic victory?

Clinical Infectious Diseases

Volumn 51, Issue 9, 2010, Pages 1108-1109

  Johnson, Lorraine ^a   Stricker, Raphael B ^a  

^a International Lyme and Associated Diseases Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; CONFLICT OF INTEREST; DECISION MAKING; LAW SUIT; LETTER; LYME DISEASE; MEDICAL SOCIETY; PEER REVIEW; PEER REVIEW ORGANIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMATIC ERROR;

CONSENSUS; HUMANS; LYME DISEASE; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 77958567803     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/656690     Document Type: Letter

References (10)

1. Lantos PM, ChariniWA, Medoff G, et al. Final report of the Lyme Disease Review Panel of the Infectious Diseases Society of America. Clin Infect Dis 2010; 51:1-5.
2. Attorney General's investigation reveals flawed Lyme disease guideline process, IDSA agrees to reassess guidelines, install independent arbiter. Office of the Attorney General, State of Connecticut, Web site. http://www.ct.gov/ag/ cwp/view.asp?ap2795&qp414284. Published 1 May 2008. Accessed 26 June 2010.
3. Johnson L, Stricker RB. The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guidelines. Philos Ethics Humanit Med 2010; 5:9. http://www.peh-med.com/content/ 5/1/9. Published 9 June 2010. Accessed 20 September 2010.
4. Patoine B. Guideline-making gets tougher: action by state Attorney General over Lyme disease guidelines stirs debate. Ann Neurol 2009; 65:A10-A15.
5. Cameron DJ. Generalizability in two clinical trials of Lyme disease. Epidemiol Perspect Innov 2006; 3:12-18.
6. Stricker RB. Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin Infect Dis 2007; 45:149-157.
7. Stricker RB, Green CL, Savely VR, Chamallas SN, Johnson L. Safety of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. Minerva Med 2010; 101:1-7.
8. Klempner MS. Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease. Vector Borne Zoonotic Dis 2002; 2(4):255-263.
9. Liu T, DeLong A, Blossom B. Challenge to IDSA recommendations for late neurologic Lyme disease treatment and post Lyme syndrome: a statistical review of NIH funded treatment studies. International Lyme and Associated Diseases Society Web site. http:// www.ilads.org/lyme-disease/lyme-testimony.html. Published 30 July 2009. Accessed 26 June 2010).
10. PRWeb. Connecticut Attorney General charges IDSA with violating Lyme antitrust settlement agreement. Earth Times Web site. http:// www.earthtimes.org/articles/show/connecticut-attorney-general-charges-idsa, 1155030.shtml.